Product Images Citalopram
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Citalopram NDC 50090-5170 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - d78873c1 29ce 478b aa3d d1a11a2750ce 01
image - d78873c1 29ce 478b aa3d d1a11a2750ce 02
Table 1 shows the drug-placebo difference in the number of suicides per 1000 patients treated in different age ranges. In patients under 18 years old, there were 14 additional cases compared to placebo, while in patients aged 18-24, there were 1624 additional cases. However, in patients aged 25 and older, the drug was associated with a decrease in the number of suicides compared to placebo, with a reduction of 564 and 265.6 fewer cases per 1000 patients treated, respectively.*
image - d78873c1 29ce 478b aa3d d1a11a2750ce 03
image - d78873c1 29ce 478b aa3d d1a11a2750ce 04
The text appears to be a table presenting the percentage of patients discontinuing treatment due to adverse events in short-term, placebo-controlled depression trials of Citalopram and Placebo. The table lists various adverse events associated with discontinuation, including asthenia, gastrointestinal disorders like nausea and vomiting, dry mouth, central and peripheral nervous system disorders like dizziness, and psychiatric disorders like insomnia, somnolence, and agitation.*
Label Image - lbl500905170
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.